The Hague February 13, 2020
New premium production for Accident & Health insurance increased by 19% to EUR 113 million.
This was predominantly driven by the Americas as a result of onboarding a significant disability contract, which more than offset lower other workplace voluntary benefits sales and the previously announced strategic decision to exit certain
products. Europe added to the increased production by a new accident product that was introduced in Spain. For property & casualty insurance, new premium production increased by 6% to EUR 64 million, driven by business growth in Spain.
Market consistent value of new business
Market
consistent value of new business (MCVNB) decreased by 17% to EUR 195 million. The decline was largely due to Variable Annuities in the United States, reflecting the significant decline in interest rates, which led to negative margins. This was
partially offset by higher MCVNB in the United Kingdom, primarily from higher margins on workplace business.
Revenue-generating investments
Revenue-generating investments increased by 3% during the second half of 2019 to EUR 898 billion. This reflects primarily favorable market movements,
which more than offset net outflows.
Shareholders equity
Shareholders equity increased by EUR 1.0 billion in the second half of 2019 to EUR 22.5 billion on December 31, 2019. This was driven by
higher revaluation reserves due to lower interest rates, and increased retained earnings which more than offset the impact of low interest rates on the remeasurement of the defined benefit obligations. Shareholders equity excluding revaluation
reserves increased by EUR 0.4 billion to EUR 16.7 billion or EUR 8.06 per common share at the end of 2019.
Gross financial
leverage ratio
The gross financial leverage ratio improved by 80 basis points to 28.5% in the second half of 2019, which is within Aegons 26%
30% target range. In the second half of 2019, Aegon successfully issued USD 925 million Tier 2 securities, with a fixed coupon of 5.1%. The proceeds were used to redeem USD 1 billion grandfathered Tier 1 securities with a coupon of
6.375%. In addition, EUR 75 million of senior debt matured in the second half of 2019. This reduction in leverage, in combination with higher shareholders equity excluding revaluation reserves, resulted in the improvement of the gross
financial leverage ratio.
Holding excess cash
Aegons holding excess cash position decreased from EUR 1,632 million to EUR 1,192 million during the second half of the year, which is within
the target range of EUR 1.0 billion to EUR 1.5 billion. The decline resulted mainly from dividends to shareholders, deleveraging, and holding funding and operating expenses more than offsetting gross remittances from subsidiaries.
The group received EUR 595 million gross remittances from subsidiaries, of which EUR 406 million came from the Americas, EUR 139 million from
Europe, EUR 27 million from Asia and EUR 20 million from Asset Management. While Aegon the Netherlands retained its planned remittances in 2019, following management actions it was within its Solvency II target range at year end, and
remitted EUR 100 million to the Group in February 2020.
Capital injections of EUR 254 million primarily related to investments in business
growth and earn-out payments in Europe. In Spain, EUR 115 million of earn-outs were paid to Santander, related to the performance of the joint venture since the start of the partnership in 2013.
Furthermore, Aegon Spain received EUR 75 million of capital injections to ensure that all legal entities Solvency II ratios remained in the target zone, as transitionals and matching adjustments are no longer used. Other capital
injections of EUR 63 million were mainly to fund business growth in the bank in the Netherlands, and Aegons Chinese insurance joint venture, Aegon THTF.
2H 2019 Results - 10